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Abstract
Background: Since 2003, a harm reduction program for injecting drug users has been rolled out countrywide in
China. It entails services for condom promotion, a needle and syringe program (NSP), and methadone maintenance
treatment (MMT). However, it remains unknown if and to what extent the coverage of these services at city level is
related to a reduced risk of HIV infection among drug users.
Methods: We wished to quantify the extent to which city-level characteristics (such as NSP and MMT service
coverage) and individual-level determinants (e.g., self-reported exposure to NSP and MMT services, knowledge,
motivation, and skills) were associated with the risk of HIV infection among drug users. In 2006, we conducted an
integrated serological and behavioral survey among drug users in five cities of Yunnan Province, China (N = 685),
constructing a multilevel logistic regression model with drug users clustered within these cities.
Results: Drug users who reported having received NSP or MMT services were about 50% less likely to be infected
with HIV than those who reported not having received them (OR 0.45, 95% CI, 0.26–0.83 for NSP and 0.48, 95% CI,
0.31–0.73 for MMT). Despite a between-city variation of HIV infection risk (ICC 0.24, 95% CI 0.08–0.54), none of the
city-level factors could explain this difference. Individual-level determinants such as perceived risk of infection and
use of condoms were not associated with HIV infection.
Conclusions: Although people who had used NSP or MMT services were less likely to be HIV infected, this study
found no relationship between city-level coverage of HIV prevention programs and variations in HIV infection
between cities. This may have been due to the low number of cities in the analysis. Future research should include
the analysis of data from a larger number of cities, which are collected widely in China through integrated
behavioral and serological surveys.
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Background
Drug users are the largest population group at risk of
HIV infection in China [1]. In 2010, the national preva-
lence of HIV among people injecting drugs was 9.1%,
with prevalence rates varying considerably across the
country: 13.6% in the Northwest, 6.3% in South Central
China, and 14.6% in the Southwest [2]. Unsafe sex and
drug use were both found to be important risk behaviors
for HIV infection among drug users [3].
Since 2005, the incidence of HIV among injecting drug
users has stabilized, possibly due to a harm reduction pro-
gram that has been conducted countrywide since 2003 [4,
5] and possibly due to other factors such as a free anti-
retroviral therapy program that started in 2002 [6]. The
harm reduction program includes services such as the
promotion of condom use, needle and syringe exchange,
and methadone maintenance treatment (MMT) [7].
As these services have been implemented to varying
extents in China’s 31 provinces and in hundreds of cities,
a snapshot of the coverage of harm reduction services
will inevitably show contrasts between cities in the same
province. For example, a study conducted in two cities
in Sichuan province reported that while only 7.8% of the
target population used any of the prevention services of-
fered in one city, 35.0% used one or more of these
services in the other city [8]. But while the coverage of
these services varies between cities, there is limited
insight into the effects of city-level coverage on the indi-
vidual risk of HIV infection.
Understanding the relationship between this coverage
and HIV infection is important for program planning and
evaluation. Theoretically, if causation exists, expanding
the coverage of prevention services at city level will reduce
the individual risk of HIV infection, regardless of the
participation of the individual drug users in the program.
If this is the case, the field workers should work on
expanding coverage as much as possible. Current practice
in China has demonstrated that, due possibly constraints
in budget and particularly human resources, coverage has
not yet reached the levels required [9, 10]. If a minimal
level of exposure is attained (e.g., 50%), field workers
should work on ensuring the quality of service delivery
and maintaining this minimal level. We hypothesize that if
coverage is high, drug users’ general attitude towards HIV
prevention will be more positive, and that they will also
support each other more in reducing their risk.
The analytical framework we chose was the
information-motivation-behavior (IMB) model, as it was
originally developed to identify the individual determi-
nants of condom-use behavior (Fig. 1). The IMB model
comprises the most complete constructs that influence
behavior changes [11, 12]. Other models are less suitable
in this respect. To increase the reliability of the analysis,
to account for the contextual factors, and to maximize
the use of our data, we extended our analysis from the
behavior outcome traditionally used in the IMB model
to a biological outcome. We also extended the IMB
model to include not only individual-level determinants
but also city-level determinants.
The effects of prevention services’ city-level coverage
on individual health can be analyzed with multilevel ana-
lysis. This approach has been used to examine other
phenomena where effects at a higher level (such as
country or neighborhood level) may affect health at the
individual level [13, 14]. Multilevel studies have been
used to examine various higher-level effects on individ-
ual health, such as the level of democratization on life
expectancy, and the effect of neighborhood characteris-
tics on individual health. Multilevel analysis was also
used to determine whether community characteristics
were associated with individual risk behavior, such as
syringe sharing, multiple sex partners, and unprotected
sex among drug users [15]. The risk environment frame-
work stated by Rhodes et al. also suggested that the
structural environmental change would shape HIV
transmission risk, either directly or indirectly [16].
In our study, we thus used multilevel analysis to inves-
tigate the association between the risk of HIV among
Fig. 1 Information-motivation-behavior and skills as applied to HIV infection among drug users, adapted from Fisher et al. 2002
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drug users, the intensity of coverage, and the individual-
level determinants. Our second objective was to explore
an analytical protocol for investigating the relationship be-
tween the individual risk of infection and other city-level
characteristics, such as the city’s level of economic devel-
opment, and the quality of harm reduction programs.
Methods
Study sites
The study was conducted from March to August 2006
in Yunnan province, Southwest China. Yunnan, a multi-
ethnic province with a long history of opium and heroin
trading and a high prevalence of illicit drug use [17], has
tended to account for at least one quarter of all HIV
cases in China [18]. HIV has spread in Yunnan primarily
through intravenous drug use with a high annual inci-
dence rate of 2.2–8.0% [19].
In 2002, a needle and syringe program (NSP) was initi-
ated by various agencies throughout China as a harm
reduction strategy. By 2009, 62 NSP centers were operat-
ing throughout Yunnan province, where over 5.3 million
syringes were distributed [20]. In 2003, as another major
component of the country’s harm reduction program for
drug users, eight pilot MMT clinics were launched in
China [21]. One of these clinics was located in Gejiu city
in Yunnan province [22].
Out of a total of 47 cities in the province, five cities
(Cuiyun, Qilin, Dali, Lufeng, and Mengzi) were sampled
on the basis of their accessibility from the provincial
capital, Kunming, and also of the interest in participa-
tion shown by local public health officials. These cities
differ according to the type of HIV prevention program
in which they participated and to the length of exposure
to such a program. In this way, each city has its own his-
tory of program implementation (see Additional file 1:
Appendix A). During project evaluation, the key infor-
mants noted that cities seem to go through a learning
phase with respect to implementing HIV prevention
programs. These informants reported that new project
activities could be set up more swiftly in cities such as
Dali and Mengzi, where participation in international
HIV/AIDS projects had started earlier, than in Cuiyun,
Qilin, and Lufeng, where it had started later [23].
Participants were recruited at three types of location
in which drug users (DUs) are often present: detoxifica-
tion centers, methadone clinics, and/or needle-exchange
centers. A detoxification center is managed by the justice
department, to which drug users are referred compulsor-
ily after having been found guilty of drug use. Metha-
done centers and needle-exchange centers are set up
and supported by the national addiction center of
China’s health department and are run by local
non-governmental organizations. In the compulsory
detoxification centers, we sampled only those drug users
who had started the programs in the previous 3 months.
This was in order to reduce the recall bias of drug users’
behavior and to avoid duplication of HIV testing. In the
voluntary harm reduction centers, participants were ei-
ther regular attendees or their drug-using acquaintances.
Data collection and ethical considerations
The data used in this study came from a cross-sectional
study that combined structured interviews with
serological testing for HIV infection. For two or three
consecutive days, staff at recruitment sites (i.e., social
and paramedical workers of voluntary harm reduction
centers) invited each client and their drug-using
acquaintances to participate. Participation in the study
was voluntary, anonymous, and confidential. Verbal in-
formed consent was obtained, and each interviewer
signed a form stating that he/she had clearly explained
the study to the participant. If a DU was reluctant to
participate, he/she was not persuaded to participate.
Each participant received the equivalent of 4 US dollars
in compensation. The interview took about 30 min and
was carried out by interviewers who had received train-
ing prior to the survey. Per site, about 150 participants
were recruited (N = 689). The Institutional Review Board
of Kunming Medical University approved all consent
forms and the study protocol, which complied with the
provisions of the Declaration of Helsinki.
Serological testing for HIV infection
Participants were tested for HIV infection according to
the Chinese national guideline for HIV/STD compre-
hensive surveillance [24]. Immediately after completion
of each interview, blood samples were taken for HIV
testing by laboratory technicians from the local Centers
for Disease Control and Prevention (CDC) [pinyin:
Jíbìng yùfáng kòngzhì zhōngxīn]. Laboratory examin-
ation of each sample entailed the use of an enzyme-
linked immunosorbent assay (ELISA) technique (Kehua
Biotech, China). Any samples that screened positive for
HIV with ELISA were confirmed by a Western blot
assay (HIV BLOT 2.2, Genelabs Diagnostics, Singapore).
Participants were informed that they could receive their
test results by calling the local CDC and providing their
study identification number or name. If they tested posi-
tive for HIV and agreed to receive free care and treat-
ment, participants would be counseled and notified of
their HIV infection status and would also be registered
in the national HIV/AIDS case reporting and surveil-
lance system. After this registration, they were entitled
to receive routine follow-up for free CD4, T cell counts
and, if appropriate, free antiretroviral treatment accord-
ing to national guidelines.
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Demographics
During the interviews, information on the following
socio-demographic factors were collected: age (years);
gender; marital status, education level (0–6 years,
primary school or lower; 6–9 years, first grade of sec-
ondary school; 9 years or above; second grade of second-
ary school); ethnic group (Han or non-Han); province of
origin according to official residence (Yunnan province
or other province); age at initiation of drug use; and
duration of drug use (number of years).
Knowledge related to HIV infection
Knowledge related to HIV infection comprised three
items:
(1)Knowledge related to modes of HIV transmission,
which was assessed on the basis of eight statements
scaled 0–1 (e.g., “HIV-positive pregnant women can
transmit HIV to their infant”). Participants were
asked whether the statements were true or false or
whether they did not know the answer. A correct
answer coded 1; an incorrect answer coded 0. “Don’t
know” responses were considered incorrect. The
sum of the number of correct responses to the eight
statements served as the score for the knowledge
level in the analysis (range 0–8).
(2)Knowing where to have an HIV test, which was
assessed by asking “do you know where to have an
HIV test?”.
(3)Knowing his/her serostatus, which was assessed by
asking “do you know your HIV test result?” “Yes”
answers were coded 1 and “no” answers were coded
0.
Motivation for preventing HIV infection
Motivation was measured on the basis of the intention
to perform healthy behavior, such as using a condom
and not sharing needles and syringes with others. Partic-
ipants were asked whether they intended to use con-
doms and whether they intended not to share needles
and syringes with others.
As described in the health belief model, perceptions of
personal risk can cause people to take protective action
[25]. In order to assess the role of these perceptions and
of the perceptions of possible negative effects of risk,
three additional questions were asked. The first question,
“How high do you think your own risk of HIV infection
is?”, was measured on a scale from 1 (no risk) to 5 (very
high), with responses being dichotomized into 1 = very
high, 0 = not high, or not at all. The second question
was “Do you think people with HIV should be allowed
to continue to work or study? (1 = yes, 0 = no)”. The
third was “Would you keep in touch with a friend with
HIV infection? (1 = yes, 0 = no)”.
HIV-protective behaviors: condom use and no drug
injection
Two HIV-protective behaviors were assessed. Drug in-
jection behavior was assessed on the basis of two items:
(1) “Have you ever injected drugs?” (2) “If yes, have you
ever shared a syringe with others?” The answers were
then combined into three categories: 2 = injecting drug
users who shared syringes, 1 = injecting drug users who
never shared a syringe, and 0 = non-injecting drug users.
Condom use was measured on the basis of the question
“Did you use a condom during your last sexual
intercourse?” (1 = yes, 0 = no).
Environmental factors
We included three categories of environmental variable.
The first—individual-level exposure to harm reduction
services in the past year—was assessed on the basis of 5
questions: (1) “Have you received free condoms in the last
year?”, (2) “Have you received training on using condoms
in the last year?”, (3) “Have you received an HIV test in
the last year?”, (4) “Have you collected NSPs in the last
year?”, and (5) “Have you received MMT in the last year?”.
All the answers were coded as “1 = yes, 0 = no”.
The second category of environmental variable was
the city-level coverage of harm reduction services. This
consisted of three variables: coverage of condom distri-
bution, coverage of NSP, and coverage of MMT, which
were all calculated by dividing the number of drug users
who reported receiving these services by the total num-
ber of drug users surveyed. The third category was city-
level indicators of economic development: population
size and GDP per capita.
Statistical analysis
The associations between individual variables and HIV
infection (yes/no) were measured in univariate and
multivariate logistic regression analyses in Stata 12
(StataCorp, College Station, Tx, www.stata.com) and in-
dicated by odds ratio (OR) with a 95% confidence inter-
val (CI). Age at initiation of drug use was transformed
into two categories (≥20 and <20 years). Duration of
drug use was also transformed (≥9 and <9 years).
The multilevel logistic regression was performed in
order to take account of the heterogeneity of HIV infec-
tion prevalence at city level [14]. Multilevel models were
constructed according to the adapted IMB model: model
0 included only HIV infection as the outcome, model 1
included two city-level coverage variables, model 2
added significant variables of individual exposure to
services, model 3 added significant determinants of the
information construct, model 4 added significant factors
of the motivation construct, and model 5 added signifi-
cant factors of the protective behaviors construct.
Models 1–5 were also adjusted for gender and province
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of origin. The level of significance used in the multilevel
analysis was 0.05. Intraclass correlation coefficients
(ICC) were used to demonstrate the magnitude of vari-
ation of HIV infection in participants located at the city
level. See Additional file 1: Appendix B for the model
studied and the Stata syntax. Only factors found to be
statistically significant at 0.10 in the multivariate logistic
regression were included in the multilevel analysis [26].
Results
Table 1 shows an overview of the characteristics of the
study population per city.
Table 2 shows the results of the univariate and multi-
variate analyses of the determinants of HIV infection in
drug users. Multivariate analysis showed that only one of
the HIV prevention services provided to drug user-
s—having received NSP or MMT—was statistically sig-
nificantly related with HIV infection. The other services
offered in the last 12 months—having received free con-
doms, received training on using of condom, received
HIV test—were not statistically significantly related with
HIV infection. The odds of HIV infection were lower in
those who had received NSP in the last year (OR = 0.58,
95% CI 0.35–0.97) and in those who had received MMT
at least once (OR = 0.59, 95% CI 0.40–0.87). Participants
who knew their serostatus were less likely to be infected
(OR = 0.63, 95% CI 0.42–0.95). Participants who per-
ceived themselves to be at a higher risk had a higher
likelihood of being infected than those who did not (OR
= 2.05, 95% CI 1.24–3.39). People who were injecting
drugs and sharing syringes at the time of the survey had
twice the risk than those who had never injected drugs
(OR = 3.04, 95% CI 1.84–5.03). Those who reported hav-
ing used a condom during their last sexual intercourse
were less likely to be infected (OR = 0.71, 95% CI 0.49–
1.03). HIV-related knowledge, intention to use a condom
and intention not to share a syringe, and other individ-
ual factors related to exposure to prevention programs
were not significantly related to HIV infection.
Table 3 shows the results of the five-step multilevel
modeling sequence. In the empty model (model 0), the
ICC was 0.24 (95% CI 0.08–0.53), indicating that 24% of
the variability in individual risk of HIV infection in drug
users could be attributed to factors that differed between
the five cities. This result confirms the contextual struc-
ture of the data and demonstrates the existence of
between-city variations. However, there were no signifi-
cant associations between any of the indicators for city-
level coverage of prevention services and the rate of HIV
infection. When individual factors (e.g., NSPs received in
the last year and types of drug use) and environmental
level factors (e.g., coverage of NSP, coverage of MMT)
were all included in the model, 24% of the variability in
propensity of HIV infection could still be contributed to
city-level variables (model 5).
The odds of HIV infection were lower among those
who had access to NSP. The estimate of this reduction
of odds is higher in a multilevel model than in a one-
level model (Tables 1 and 2 OR 0.43 vs. OR 0.60,
respectively). To a different extent, there was a similar
difference of estimates for having had access to MMT
(OR 0.47 vs. OR 0.61), and for the risk-inducing effect of
injecting drug use relative to that for non-injecting drug
use (OR 3.22 vs. OR 3.04 and OR 2.14 vs. OR 2.00).
Discussion
In this study, we found that several individual determi-
nants and perceived environmental determinants were
associated with individual risk of HIV infection. Our re-
sults suggest that people who reported having been
exposed to NSP or MMT services in the past year were
at a lower risk of HIV infection. Further, while this study
demonstrated considerable between-city variations in
HIV infection, we found no evidence that the city-level
availability and coverage of services was related to the
spread of HIV infection.
Main finding: environmental determinants
A drug user’s knowledge of his/her serostatus was found
to be associated with lower odds of HIV infection.
People who are currently engaged in risky drug-use be-
havior (i.e., injecting drugs and/or sharing a syringe) had
50% higher odds of infection. However, this study did
not demonstrate that a drug user’s risk of HIV infection
was related to city-level coverage of prevention services.
Compared to the single level model, the multilevel
model showed values of odds ratio that indicated the fol-
lowing: (1) that there was a greater protective effect
from harm reduction (measured as received NSP and re-
ceived MMT in the last 12 months) and (2) that there
was a higher risk of HIV infection from injecting drug
use than from non-injecting drug use (measured with
two indicators, each comparing a risk behavior with the
reference of non-injecting drug use; [i] current injection
drug users who have shared syringes and [ii] current in-
jection drug users who have not). At this point it is rele-
vant to note that multilevel analysis is considered to
produce a less biased estimate of effect than single-level
analysis of clustered datasets [27–29].
There are two possible reasons for the lack of an asso-
ciation we found between coverage of prevention
services at the city level and drug users’ risk of HIV
infection: the sampling was not done at random, and too
few cities were included in the study. As many partici-
pants were recruited at centers that offered voluntary
harm reduction services, variation in the measurement
across cities may have been lower, which may have
Wu et al. Harm Reduction Journal  (2017) 14:10 Page 5 of 12
Table 1 HIV infection status, potential determinants of HIV infection and socio-demographic characteristics of drug users in five
cities (N = 685)
Variables Total Cities
Dali Qilin Cuiyun Lufeng Mengzi
685 162 173 65 139 146
N % N % N % N % N % N %
Demographics
Mean age (years) 31.5 6.3 31.9 7.5 30.7 5.4 31.9 6.0 30.1 6.0 32.3 6.3
Gender
Male 539 78.7 129 79.6 129 74.6 49 75.4 104 74.8 128 87.7
Female 146 21.3 33 20.4 44 25.4 16 24.6 35 25.2 18 12.3
Education level (years)
0–6 183 26.7 70 43.2 18 10.4 14 21.5 28 20.1 53 36.3
6–9 353 51.5 67 41.4 108 62.4 32 49.2 81 58.3 65 44.5
9– 149 21.8 25 15.4 47 27.2 19 29.2 30 21.6 28 19.2
Ethnic group
Han 531 77.5 92 56.8 161 93.1 46 70.8 115 82.7 117 80.1
Non-Han 154 22.5 70 43.2 12 6.9 19 29.2 24 17.3 29 19.9
Official residence
Yunnan province 609 88.9 128 79.0 165 95.4 62 95.4 118 84.9 136 93.2
Other provinces 76 11.1 34 21.0 8 4.6 3 4.6 21 15.1 10 6.8
Age at initiation of drug use (years)
≥20 464 67.7 121 74.7 128 74.0 43 66.2 84 60.4 88 60.3
<20 221 32.3 41 25.3 45 26.0 22 33.8 55 39.6 58 39.7
Duration of drug use (years)
≥9 371 54.2 71 43.8 83 48.0 37 56.2 84 60.4 96 65.8
<9 314 45.9 91 56.2 90 52.0 28 43.1 55 39.6 50 34.3
HIV positive 295 43.1 47 29.0 122 70.5 12 18.5 23 16.6 91 62.3
City-level variables: two composite indicators of exposure and two indicators of economic development
Density of exposure to HIV preventiona – – 0.05 0.10 0.06 0.06 0.03
Performance of drug injection safetya – – 0.06 0.05 0.04 0.07 0.09
Population size in 2006b – – 603199 665724 255507 420846 344987
GDP per capita in 2006 (CNY)b – – 18294 26189 10208 11086 9242
Individual variables exposure to prevention services in the last 12 months
Received free condoms
Yes 119 17.4 35 21.6 40 23.1 9 13.9 23 16.6 12 8.2
No 566 82.6 127 78.4 133 76.9 56 86.1 116 83.4 134 91.8
Received training on how to use a condom
Yes 206 30.0 41 25.3 68 39.3 15 23.1 37 26.6 45 30.8
No 479 70.0 121 74.7 105 60.7 50 76.9 102 73.4 101 69.2
Received test for HIV
Yes 392 57.2 85 52.5 114 65.9 52 80.0 96 69.1 45 30.8
No 293 42.8 77 47.5 59 34.1 13 20.0 43 30.9 101 69.2
Received NSPs
Yes 105 15.3 28 17.3 45 26.0 9 13.9 20 14.4 3 2.1
No 580 84.7 134 82.7 128 74.0 56 86.1 119 85.6 143 97.9
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contributed to non-significant findings for the city-level
variables. Similarly, to influence population-level
changes in rates of HIV infection, these services also
have to reach a sufficient coverage level—50%, for ex-
ample [30, 31]. However, as the data were collected in
2006, the year in which the harm reduction program
had started, coverage of MMT and NSP were still low,
with the highest coverage of MMT reaching only 41%
within only one city. As coverage of MMT increases,
one could expect that risk behavior decreases. Indeed,
nation-wide analysis of surveillance site data from China
found that the increase of MMT coverage from 2004 to
2011 is correlated with a decrease in needle sharing
among IDUs who reported sharing needles in the past
Table 1 HIV infection status, potential determinants of HIV infection and socio-demographic characteristics of drug users in five
cities (N = 685) (Continued)
Received MMT
Yes 219 31.9 44 27.2 71 41.0 22 33.9 43 30.9 39 26.7
No 466 68.0 118 72.8 102 59.0 43 66.2 96 69.1 107 73.3
Information/knowledge
Score of 8 HIV related questions (median) 0–8 7 7 7 7 6 7
Knowing where to have a HIV test
Yes 456 66.6 97 60.0 138 80.0 52 80.0 103 74.1 66 45.2
No 229 33.4 65 40.0 35 20.0 13 20.0 36 25.9 80 54.8
Knowing his/her serostatus
Yes 153 22.4 27 16.7 45 26.2 32 49.2 31 22.2 18 12.3
No/have not been tested 532 77.6 135 83.3 128 73.8 33 50.8 108 77.8 128 87.7
Motivation
Self-perceived risk of HIV infection
Very likely 90 13.1 8 4.9 33 19.1 3 4.6 18 13.0 28 19.2
Possibly/not possible 595 86.9 154 95.1 140 80.9 62 95.4 121 87.0 118 80.8
Perceived severity of getting infection of HIV
Should people with HIV be allowed to continue to work or study?
Yes 502 73.3 103 63.6 135 78.0 45 69.2 106 76.3 113 77.4
No/it depends/do not know 183 26.7 59 36.4 38 22.0 20 30.8 33 23.7 33 22.6
Are you willing to remain in contact with a friend with HIV infection?
Yes 537 78.4 114 70.4 139 80.3 56 86.1 112 80.6 116 79.4
No/it depends/do not know 148 21.6 48 29.6 34 19.7 9 13.9 27 19.4 30 20.6
Had the intention of using condom
Yes 585 85.4 137 84.6 151 87.3 49 75.4 122 87.8 126 86.3
No/not sure 100 14.6 25 15.4 22 12.7 16 24.6 17 12.2 20 13.7
Had the intention of not sharing needles and syringes with others
Yes 569 83.1 129 79.6 148 85.6 48 73.9 110 79.1 134 91.8
No 116 16.9 33 20.4 25 14.4 17 26.1 29 20.9 12 8.2
Risk behavior or prevention skills
Current drug user status
Never injected drugs 140 20.4 69 42.6 24 13.8 9.0 13.8 25 18.0 13 8.9
Current injection drug users but not sharing syringe 269 39.3 41 25.3 70 40.5 50 76.9 57 41.0 51 34.9
Current injection drug users and sharing syringe 276 40.3 52 32.1 79 45.7 6 9.3 57 41.0 82 56.2
Used condom during last sexual intercourse with partner/sex worker/client
Yes 211 30.8 50 30.9 46 26.6 24 36.9 42 30.2 49 33.6
No/not applicable 474 69.2 112 69.1 127 73.4 41 63.1 97 69.8 97 66.4
aAdditional file 1; Appendix C explains how the two composite indicators density of exposure to HIV prevention and performance of drug injection safety
are calculated
bsource; Yunnan Province Statistics Yearbook
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1 month [32]. Future studies which study differences of
the relationship between coverage and HIV infection be-
tween cities should therefore use randomized sampling
methods, include more cities and more drug users per
city sampled, and collect data in cities with higher
coverage.
We should add that program coverage is a more com-
plex indicator than a single individual level indicator,
such as having received MMT or NSP. Given the fact
that some cities were better at scaling up one service
and less experienced with other services at a given time-
point, we performed additional analysis with a new vari-
able for city-level program coverage, in which we com-
bined data on exposure to five different services. After
presenting the data on exposure to five different services
in a radar chart, we calculated the surface area of the
radar as a proxy for total exposure levels. In a similar
way, we constructed a new variable for the city-level
performance of safe drug-injection practices (Additional
file 1: Appendix C). However, neither of these two mea-
sures showed an association with HIV infection.
Although we also used population size and GDP per
Table 2 Univariate and multivariate analysis of determinants of HIV infection in drug users in five cities (N = 685)
Variables Univariate p Multivariate p
OR 95%CI OR 95%CI
Exposure to HIV prevention program in the last 12 months
Received free condoms 0.64 0.43–0.98 0.04 ** NS.
Received training on using of condom 1.04 0.75–1.44 0.83 #
Received HIV test 0.89 0.66–1.21 0.45 #
Received NSPs 0.59 0.38–0.91 0.02 ** 0.60 0.36–0.99 0.05 **
Received MMT 0.63 0.46–0.88 0.01 *** 0.61 0.42–0.91 0.02 **
Information
Knowledge score of 8 questionsa 0.99 0.90–1.08 0.76 #
Knowing where to have a HIV test 1.19 0.87–1.65 0.28 #
Knowing his/her serostatus 0.63 0.44–0.92 0.02 ** 0.63 0.42–0.95 0.03 **
Motivation
Perceived risk of HIV infection 2.45 1.55–3.87 <0.001 *** 2.05 1.24–3.39 <0.01 ***
Should people with HIV be allowed to continue to work or study? 0.91 0.65–1.28 0.58 #
Are you willing to remain in contact with a friend with HIV infection? 0.86 0.60–1.24 0.42 #
Had intention of using condom 0.87 0.57–1.33 0.52 #
Had intention of not sharing needles and syringes with others 1.04 0.70–1.56 0.84 #
Risk behavior or prevention skills
Types of drug use
• Current injecting drug users but not sharing syringes vs. never injected drugs 2.22 1.40–3.50 0.00 *** 2.00 1.22–3.27 <0.01 ***
• Current injecting drug users and sharing syringes vs. never injected drugs 3.65 2.32–5.75 <0.001 *** 3.04 1.84–5.03 <0.01 ***
Used of condom during the last sexual intercourse 0.73 0.52–1.03 0.07 * 0.71 0.49–1.03 0.07 *
Demographics
Age 1.02 1.0–1.05 0.05 ** NS.
Gender (male vs. female) 0.48 0.32–0.71 <0.001 *** 0.56 0.36–0.86 <0.01 ***
Education level 0.95 0.76–1.18 0.63 #
Han ethnic group 1.54 1.06–2.23 0.02 ** NS.
Official residence; Yunnan province 0.11 0.05–0.25 <0.001 *** 0.14 0.06–0.32 <0.01 ***
Age at initiation of drug use >20 years 1.00 0.73–1.38 0.98 #
Duration of drug use >9 years 1.55 1.14–2.11 0.01 *** NS.
Notes: Significant values are in bold
CI confidence interval, DU drug users, OR odds ratio, NS. variables with p < 0.1 in the univariate analyses but with a significance of p > 0.1 in the multivariate
analysis were not included in the multilevel analysis
*p < 0.1; **p < 0.05; ***p < 0.01
aThe eight knowledge questions were whether HIV could be transmitted via sexual intercourse, toilet seats, needle sharing, mother to child transmission, blood
transmission, mosquito bites, and shaking someone’s hand
#Variables with p > 0.1 in the univariate analyses and were not used in the subsequent analyses
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capita in 2006 as city-level variables, none of them
showed an association (result not shown).
Main finding: individual determinants
The individual determinants used were based on the
adapted IMB model similar to that used by four previous
studies [33–36]. As in those studies, not all the con-
structs of the model were significantly associated with
HIV infection, and only the proximal factors were sig-
nificant. There are four possible reasons for this. First,
the measurement used for data collection was not opti-
mal, i.e., the questions used to assess HIV/AIDS-related
knowledge may not have been sufficiently specific to
drug users. Second, as all the behavior data were self-
reported, reporting bias was inevitable. Third, despite
the model’s great utility as a framework for guiding HIV
risk-reduction interventions, not all its single constructs
need to be shown to be statistically significant to deter-
mine its expected outcome for the model to be applied
in studies that compare differences between cities [37].
Fourth, the constructs in the early phase of change in
the IMB model (e.g., motivation) are not important
enough to trigger behavior change and to then reduce
the risk of HIV infection.
Other possible environmental determinants
Although it is generally accepted that harm reduction is
an effective way of reducing HIV infection, its careful
implementation as recommended by UNODC is still a
problem in many countries [5]. With regard to this rec-
ommendation, the criminalization of injecting drug users
in China remains a major barrier to harm reduction ser-
vices, as it may lead to discrimination or disapproval
from the community, preventing many people who
inject drugs from accessing NSP services.
Although harm reduction programs started several
years ago in China, their coverage is still less than
optimal. A recent study from the region of our survey
reported that the coverage of NSP was only 28–32%
and that the coverage of MMT was 11.4%—both far
short of the central government’s targets of 50% by
2010 [10]. In an additional analysis, we used the gen-
eral population’s awareness of and support for harm
reduction to incorporate a fourth category of environ-
mental factor into the multilevel model; the city-level
stigma of HIV. Measurement of stigma was based on
the questions as follows: “Will you keep contact with
a friend who has HIV?”, “Do you know NSP?”,
“Would you agree to have an NSP clinic in your
neighborhood”, “Do you know MMT?”, “Would you
agree to have MMT clinic in your neighborhood?”.
The indicators of stigma were extracted from an add-
itional survey conducted in the general population of
the five participating cities at the same time as the
survey of drug users. Cities where a larger part of the
population knew and supported NSP or MMT also
Table 3 Multilevel regression analysis of determinants of HIV infection in drug users (N = 685)
Model 1 Model 2 Model 3 Model 4 Model 5 Final model
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Exposure to HIV prevention program in the last 12 months
Received NSPs 0.52 (0.30–0.92) 0.53 (0.30–0.94) 0.54 (0.30–0.95) 0.45 (0.25–0.80) 0.46 (0.25–0.82) 0.43 (0.24–0.77)
Received MMT 0.54 (0.35–0.82) 0.55 (0.36–0.84) 0.56 (0.35–0.84) 0.48 (0.31–0.75) 0.48 (0.31–0.75) 0.47 (0.30–0.72)
Information
Knowing his/her serostatus 0.73 (0.46–1.15) 0.69 (0.43–1.10) 0.65 (0.40–1.04) 0.66 (0.41–1.06)
Motivation
Perceived risk of HIV infection 1.89 (1.09–3.28) 1.63 (0.93–2.86) 1.66 (0.94–2.93)
Risk behavior or prevention skills
Types of drug use
• Current injecting drug users but
not sharing syringes vs. never
injected drugs
2.25 (1.28–3.96) 2.22 (1.26–3.92) 2.14 (1.22–3.75)
• Current injecting drug users and
sharing syringes vs. never injected
drugs
3.13 (1.76–5.57) 3.15 (1.77–5.61) 3.22 (1.83–5.68)
Used condom during the last sexual intercourse 0.72 (0.48–1.08)
ICC * 0.24 (0.08–0.53) 0.24 (0.08–0.53) 0.24 (0.08–0.53) 0.24 (0.08–0.53) 0.24 (0.08–0.53) 0.24 (0.08–0.53)
Note: All models were adjusted for gender and province of origin. Bold figures indicate statistically significant at 0.05
*ICC intraclass correlation coefficient
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had lower HIV infection rates in drug users (results
available upon request from the first author).
As WHO has stated, the total number of sterile nee-
dles and syringes provided per drug injector per year is
also crucial [38]. Unfortunately, these figures from Yun-
nan province’s cities were not available for the period of
our study; the Health Bureau of Yunnan province
reported these for the first time only in 2014 [39].
Further studies should take this issue into consideration.
Limitations
A limitation of this study is that the data collected did
not allow for a sensitivity analysis with respect either to
the type of sampling location or to a drug user’s history
of exposure to the three different types of location
(detoxification center, methadone clinic, and needle-
exchange center), as information on the types of
sampling location was not recorded. Only for one city
(Mengzi) is it known that all participants were recruited
at a detoxification center. Another limitation is although
male-male sex carries high risk of HIV transmission, the
prevalence of male-male sex was very low in our sample
(1%), and we therefore did not include it in the analysis.
The last limitation is that the criminalization and
stigmatization of drug use probably led participants in
the study to under-report their current drug use [40].
Unfortunately, as Bergenstrom and Abdul-Quader have
reported, the existence of two detoxification systems
(voluntary and compulsory) seems to hinder the
implementation of harm reduction programs [41].
Recommendations
To our knowledge, no other study has examined the
association between city-level prevention characteristics
and individual HIV infection risk. Such kinds of analysis are
nonetheless important; a known quantified statistical asso-
ciation would make it easier to track progress more accur-
ately, linking properly distributed project activities with
their intended effects. For this reason, the World Health
Organization encourages the linking of biological and be-
havioral data [42]. We recommend that future studies
examine the influence of other city-level prevention charac-
teristics that were not measured but might be related to
drug users’ risk of HIV infection, such as the availability of
local policies on HIV prevention for the target population.
Despite the non-significant results produced by our
analysis of the association between city-level variables
and risk of HIV infection, this study indicates the need
for a new analytical approach. As two aspects of our
approach are rather novel, they enrich the methodolo-
gies that are currently available. By quantifying the asso-
ciation between city-level prevention programs and the
individual risk of HIV infection, this study is a pioneer
study. Our multilevel analytical approach might be
suitable for a simultaneous study of city-level and
individual-level determinants. By taking account of the
hierarchical nature of the dataset, our use of a multilevel
analysis also allowed us to obtain a less biased result.
We should add that it is necessary to use the adapted
IMB model to structure the variables. This has the
potential to facilitate structural thinking when develop-
ing an intervention program.
Our results allow us to present two main recommen-
dations for future studies. First, studies should use a
larger sampling size in a larger number of cities and in
more drug users per city. Since 2006, integrated behav-
ioral and serological surveys have been conducted
routinely in an increasing number of Chinese cities,
reaching an estimated 400 surveillance sites in 2014 [24,
43, 44]. Second, future studies should also use more
specific constructs of the IMB model and include other
variables that are likely to be related to the characteris-
tics of prevention programs at city level. These variables
include economic development, local policies on HIV
prevention in drug users, the number of healthcare and
prevention professionals, the number of needles and
methadone doses distributed through NSP and MMT,
the number or density of NSPs/MMT sites, and the
quality of MMT and NSP services.
Conclusions
People exposed to NSP or MMT services prior to HIV
testing were found to be at lower risk of HIV infection
than people lacking such exposure. It is widely known
that a comprehensive approach to harm reduction can
reduce HIV infection effectively among drug users [9,
45, 46]. It is important to program planning and evalu-
ation to understand the extent to which the availability
and coverage of prevention services can be related to the
spread of HIV infection in high-risk groups. If such a
relationship existed and could be quantified, this could
help to allocate available resources more effectively per
city.
This study found that 24% of the variation of the risk
of HIV-infection comes from city-level characteristics
(ICC : 0.24). However, our analysis did not find that the
city-level variables of availability and coverage which
were used in this study were related to risk of HIV infec-
tion. It has nonetheless demonstrated the potential for
combining the data that have become available since
1998 as part of China’s widespread collection of inte-
grated behavioral and serological surveys. By analyzing a
larger sample of cities, and, if possible, sampling more
study participants per city, future studies might be able
to demonstrate how the availability and coverage of pre-
vention services and other city-level modifiable factors
are related to the spread of HIV infection.
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